ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition-Reference-Cited by-同舟云学术

ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition

Published:2017-02 Issue:6 Volume:18 Page:1543-1557
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Wang Belinda,Krall Elsa Beyer,Aguirre Andrew James,Kim Miju,Widlund Hans Ragnar,Doshi Mihir Bhavik,Sicinska Ewa,Sulahian Rita,Goodale Amy,Cowley Glenn Spencer,Piccioni Federica,Doench John Gerard,Root David Edward,Hahn William Chun

Funder

Hope Funds for Cancer Research

NIH F32

Pancreatic Cancer Action Network Samuel Stroum Fellowship

Hope Funds for Cancer Research Postdoctoral Fellowship

American Society of Clinical Oncology Young Investigator Award

Dana Farber Cancer Institute Hale Center for Pancreatic Cancer

Perry S. Levy Endowed Fellowship

Harvard Catalyst and Harvard Clinical and Translational Science Center

Next Generation Fund

Broad Institute

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference61 articles.

1. A MAPK docking site is critical for downregulation of Capicua by torso and EGFR RTK signaling;Astigarraga;EMBO J.,2007

2. The E3 ubiquitin ligase complex component COP1 regulates PEA3 group member stability and transcriptional activity;Baert;Oncogene,2010

3. Mutations in CIC and FUBP1 contribute to human oligodendroglioma;Bettegowda;Science,2011

4. Characterization of human constitutive photomorphogenesis protein 1, a RING finger ubiquitin ligase that interacts with Jun transcription factors and modulates their transcriptional activity;Bianchi;J. Biol. Chem.,2003

5. c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma;Blasco;Cancer Cell,2011

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS - and BRAF -mutant cancer cells;Science Signaling;2024-05-14

2. GPRC5A promotes paclitaxel resistance and glucose content in NSCLC;Anti-Cancer Drugs;2024-04-08

3. Activation of endogenous retroviruses and induction of viral mimicry by MEK1/2 inhibition in pancreatic cancer;Science Advances;2024-03-29

4. Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy;Molecular Cancer;2024-01-09

5. Inactivation of p53 drives breast cancer brain metastasis by altering fatty acid metabolism;2023-12-20